[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]

G Ital Cardiol (Rome). 2022 Jun;23(6 Suppl 1):e3-e115. doi: 10.1714/3808.37926.
[Article in Italian]
No abstract available

MeSH terms

  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / prevention & control
  • Europe
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Primary Prevention

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors